Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 19;56(1):81.
doi: 10.1007/s12029-025-01197-w.

Expression Levels of Plasma YRNAs in Colorectal Cancer as a Potential Noninvasive Biomarker

Eman Tayae  1   2 , Eman M Osman  3 , Marwa R Tawfik  4 , Neamat Hegazy  5 , Marwa Moaaz  6 , Rasha A Ghazala  7
Affiliations

Expression Levels of Plasma YRNAs in Colorectal Cancer as a Potential Noninvasive Biomarker

Eman Tayae et al. J Gastrointest Cancer. .

Abstract

Purpose: Colorectal cancer (CRC) is identified as the second leading cause of cancer-associated deaths worldwide. Therefore, there is ongoing research to discover new potential biomarkers enabling early and noninvasive diagnosis of the disease. YRNAs, a novel class of non-coding RNAs, have been identified as a new player in carcinogenesis and an independent class of clinical biomarkers in various malignancies. Nevertheless, the role of plasma YRNAs in CRC diagnosis and prognosis remains unknown. Therefore, the current study aimed to investigate the clinical significance of plasma YRNAs as a noninvasive biomarker for CRC.

Methods: Plasma YRNAs expression was assessed in 50 newly diagnosed CRC patients as well as 50 age- and sex-matched healthy controls using quantitative reverse transcription polymerase chain reaction.

Results: All plasma YRNAs expression levels were significantly higher in CRC patients than in controls. A significant correlation was observed between YRNA1 and YRNA3, and between YRNA1 and YRNA4. However, no significant correlation between YRNA1 and YRNA5 was identified. Plasma YRNA1 expression showed the highest diagnostic performance for the detection of CRC using the receiver operating characteristic curve analysis, with a sensitivity of 92% and a specificity of 90%. Nevertheless, when the four YRNAs were combined in a single ROC analysis, sensitivity decreased to 80%, while the specificity remained virtually unchanged. Moreover, significant association was observed between plasma YRNA1 and YRNA3 and tumor stage, grade, lymph node presence, metastasis, and lymphovascular invasion.

Conclusions: Plasma YRNA may serve as a potential noninvasive biomarker for the diagnosis and prognosis of CRC with high sensitivity and specificity vs. healthy controls.

Keywords: Biomarkers; Colorectal cancer; Noninvasive; YRNAs.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics Approval and Consent to Participate: The study was approved by the Ethics Committee of Alexandria University, Egypt. Informed consent was obtained from all individual participants included in the study. All methods were performed in accordance with the relevant guidelines and regulations. Consent for Publication: The manuscript has been approved by the included authors. Competing Interests: The authors declare no competing interests.

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. - DOI - PubMed
    1. Brand L, Khamess S, Abdelmoneim SE, Arafat W, Fouad MN, Khamis Y, et al. Designing an effective colorectal cancer screening program in Egypt: a qualitative study of perceptions of Egyptian primary care physicians and specialists. Oncologist. 2020;25:e1525–31. - DOI
    1. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490–502. - DOI - PubMed
    1. Kaminski MF, Robertson DJ, Senore C, Rex DK. Optimizing the quality of colorectal cancer screening worldwide. Gastroenterology. 2020;158:404–17. - DOI - PubMed
    1. Rabeneck L, Chiu HM, Senore C. International perspective on the burden of colorectal cancer and public health effects. Gastroenterology. 2020;158:447–52. - DOI - PubMed

LinkOut - more resources